Cannabinoids, sleep, and the MCH system
- ,
- Daniela Morales-Lara,
- José Carlos Pastrana-Trejo,
- Lorena Macías-Triana,
- Karen Romero-Cordero,
- Miriel de-la-Cruz
- ,
- Intercontinental Neuroscience Research Group,
- Universidad Anáhuac,
- Centro de Investigacion Cientifica de Yucatan
Publication Information
Output type
Host publication Subtitle
Molecular, Functional and Clinical AspectsOriginal language
EnglishPages from-to (Number of pages)
Pages 121-130 (10 pages)Publication milestones
- Published - 17/04/2018
Publication status
Publisher
Taylor and FrancisISBN (Print)
9783319757643ISBN (Electronic)
9783319757650Publication IDs
- Scopus: 85070025856
Host publication title
Melanin-Concentrating Hormone and SleepAbstract
Marijuana is a colloquial name given to Cannabis sativa, which has been used for diverse purposes, including as a therapeutical element for multiple health issues. The neurobiological effects of C. sativa involve a complex biological machinery including receptors, named CB1 and CB2 cannabinoid receptors. These receptors recognize endogenous cannabinoid-like compounds, such as anandamide and 2-arachinonolglycerol which seems to display sleep-inducing properties. Along decades, the study of the putative role of exogenous and endogenous cannabinoids in sleep modulation has brought critical data. Since endocannabinoids have been described in sleep-related brain areas, intriguing issues regarding whether hypothalamic substrates, such as MHC, may be interacting with the endocannabinoids have been raised.
